Arthex Biotech is a startup based in Spain, 4 tracked investors.
Arthex Biotech is a company founded in 2025 headquartered in Spain. Brouky records 4 investors associated with the company.
Arthex Biotech develops RNA-based medicines focused on anti-miR therapies targeting diseases with unmet medical needs, including their lead program for Myotonic Dystrophy.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.